Back to today’s briefing

Story perspectives

Lindus Health Secures $55M for Innovative AI Trials

1/23/2025

36 8

Summary

Story summary

Lindus Health, a trailblazer in clinical trials, has secured $55 million in Series B funding, spearheaded by Balderton Capital. Since its inception in 2021, the New York-based company has harnessed its innovative AI platform, Citrus™, to streamline trials, successfully enrolling over 36,000 patients in 42 studies across North America and Europe.

History

Historical Context

Lindus Health's $55 million funding mirrors the 1990s biotech boom, where innovation surged amid technological advances. Just as companies then transformed healthcare through new therapies, Lindus aims to revolutionize clinical trials with AI, reflecting a continuous trend of leveraging technology for patient-centric solutions.

1 of 2

Story summary

Lindus Health, a trailblazer in clinical trials, has secured $55 million in Series B funding, spearheaded by Balderton Capital. Since its inception in 2021, the New York-based company has harnessed its innovative AI platform, Citrus™, to streamline trials, successfully enrolling over 36,000 patients in 42 studies across North America and Europe.

1 / 2